Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

210Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Monoclonal chronic lymphocytic leukemia (CLL)-phenotype cells are detectable in 3.5% of otherwise healthy persons using flow cytometric analysis of CDS/CD20/CD79b expression on CD19-gated B cells. To determine whether detection of such CLL-phenotype cells is indicative of an inherited predisposition, we examined 59 healthy, first-degree relatives of patients from 21 families with CLL. CLL-phenotype cells were detected in 8 of 59 (13.5%) relatives, representing a highly significant increase in risk (P = .00002). CLL-phenotype cell levels were stable with time and had the characteristics of indolent CLL. Indolent and aggressive clinical forms were found in family members, suggesting that initiation and proliferation involves distinct factors. The detection of CLL-phenotype cells provides a surrogate marker of carrier status, potentially facilitating gene identification through mapping in families and direct analysis of isolated CLL-phenotype cells. © 2002 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Rawstron, A. C., Yuille, M. R., Fuller, J., Cullen, M., Kennedy, B., Richards, S. J., … Houlston, R. S. (2002). Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood, 100(7), 2289–2291. https://doi.org/10.1182/blood-2002-03-0892

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free